X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Prism Johnson Ltd.
BSE CODE: 500338   |   NSE CODE: PRSMJOHNSN   |   ISIN CODE : INE010A01011   |   13-Mar-2026 Hrs IST
BSE NSE
Rs. 125.40
0.3 ( 0.24% )
 
Prev Close ( Rs.)
125.10
Open ( Rs.)
125.45
 
High ( Rs.)
128.00
Low ( Rs.)
125.00
 
Volume
8706
Week Avg.Volume
10350
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 125.21
0.03 ( 0.02% )
 
Prev Close ( Rs.)
125.18
Open ( Rs.)
125.00
 
High ( Rs.)
127.80
Low ( Rs.)
124.90
 
Volume
283482
Week Avg.Volume
208811
 
52 WK High-Low Range(Rs.)
114.72
176
Source DateBoard Meeting DateDetails
30-Jan-2026 06-Feb-2026 Quarterly Results
03-Nov-2025 07-Nov-2025 Quarterly Results
24-Oct-2025 31-Oct-2025 Quarterly Results(Cancelled) (Cancelled)
04-Aug-2025 07-Aug-2025 Quarterly Results Inter alia, shall also consider the proposal of raising further capital and to create, offer, issue and allot such number of equity shares and equity linked instruments, including convertible preference shares, non-convertible debt instruments along with warrants, fully convertible debentures, partly convertible debentures, or warrants entitling the warrant holder(s) to apply for equity shares, or any other eligible securities through further public issue of equity/debt securities, and/or private placement and/or by way of one or more qualified institutions placement or preferential issue or a rights issue or through any other permissible mode under applicable laws, and/or any combination thereof, in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and all other applicable laws, as may be considered appropriate, subject to such statutory /regulatory/other approvals as may be required, including the approval of the members, to seek their consent for such fund raising and ancillary actions for such fund raising.
04-Aug-2025 07-Aug-2025 Quarterly Results Inter alia, shall also consider the proposal of raising further capital and to create, offer, issue and allot such number of equity shares and equity linked instruments, including convertible preference shares, non-convertible debt instruments along with warrants, fully convertible debentures, partly convertible debentures, or warrants entitling the warrant holder(s) to apply for equity shares, or any other eligible securities through further public issue of equity/debt securities, and/or private placement and/or by way of one or more qualified institutions placement or preferential issue or a rights issue or through any other permissible mode under applicable laws, and/or any combination thereof, in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and all other applicable laws, as may be considered appropriate, subject to such statutory /regulatory/other approvals as may be required, including the approval of the members, to seek their consent for such fund raising and ancillary actions for such fund raising.
30-Jul-2025 07-Aug-2025 Quarterly Results Inter alia, shall also consider the proposal of raising further capital and to create, offer, issue and allot such number of equity shares and equity linked instruments, including convertible preference shares, non-convertible debt instruments along with warrants, fully convertible debentures, partly convertible debentures, or warrants entitling the warrant holder(s) to apply for equity shares, or any other eligible securities through further public issue of equity/debt securities, and/or private placement and/or by way of one or more qualified institutions placement or preferential issue or a rights issue or through any other permissible mode under applicable laws, and/or any combination thereof, in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and all other applicable laws, as may be considered appropriate, subject to such statutory /regulatory/other approvals as may be required, including the approval of the members, to seek their consent for such fund raising and ancillary actions for such fund raising.
08-May-2025 15-May-2025 Audited Results
27-Jan-2025 06-Feb-2025 Quarterly Results
04-Nov-2024 13-Nov-2024 Quarterly Results
01-Aug-2024 09-Aug-2024 Quarterly Results
Page 1 of 11
PREV || NEXT